Key Insights
The Australian mammography market, valued at $69.28 million in 2025, is projected to experience robust growth, driven by a rising prevalence of breast cancer, increasing awareness about early detection, and technological advancements in mammography systems. The market's Compound Annual Growth Rate (CAGR) of 9.27% from 2025 to 2033 indicates substantial expansion. Key growth drivers include the adoption of advanced technologies like digital mammography and breast tomosynthesis, offering superior image quality and improved diagnostic accuracy. The increasing number of hospitals, specialty clinics, and diagnostic centers equipped with advanced mammography systems further fuels market expansion. While the market faces potential restraints such as high equipment costs and the need for skilled professionals, the overall positive demographic trends and government initiatives promoting early breast cancer detection are expected to offset these challenges. Segmentation analysis reveals a strong demand for digital mammography systems, reflecting a clear industry trend toward superior image quality and reduced radiation exposure. Leading market players such as Siemens Healthineers, Hologic Inc., and GE Healthcare are actively investing in research and development, launching innovative products, and expanding their market presence to capitalize on this growth opportunity.
The competitive landscape is marked by the presence of both established multinational corporations and specialized companies focusing on specific aspects of mammography technology. The increasing adoption of advanced imaging techniques like tomosynthesis is creating new opportunities for market players. The historical period from 2019 to 2024 exhibited consistent growth, setting a strong foundation for the projected expansion throughout the forecast period (2025-2033). Future growth will likely be influenced by factors including government healthcare policies, reimbursement rates, and the continued advancement of mammography technology. The focus on preventative healthcare and the increasing emphasis on early cancer detection will further propel the Australian mammography market's growth in the coming years.

Australia Mammography Market Report: 2019-2033
This comprehensive report provides an in-depth analysis of the Australian mammography market, encompassing market size, growth drivers, technological advancements, competitive landscape, and future projections from 2019 to 2033. The study period covers 2019-2033, with 2025 as the base and estimated year. The forecast period spans 2025-2033, and the historical period encompasses 2019-2024. This report is crucial for stakeholders seeking to understand the dynamics of this vital healthcare sector in Australia.
Australia Mammography Market Composition & Trends
The Australian mammography market is characterized by a moderately concentrated landscape, with key players such as Siemens Healthineers, Hologic Inc, and GE Healthcare holding significant market share. Market share distribution fluctuates, with estimates suggesting Siemens Healthineers holding approximately xx% in 2025, followed by Hologic Inc at xx% and GE Healthcare at xx%. Innovation is driven by advancements in digital mammography, breast tomosynthesis, and AI-powered diagnostic tools. The regulatory landscape, governed by bodies like the Therapeutic Goods Administration (TGA), plays a significant role in shaping market access and adoption of new technologies. Substitute products, including ultrasound and MRI, present some competitive pressure but remain niche options for mammography’s core applications. The end-user profile consists primarily of hospitals (xx% market share in 2025), specialty clinics (xx%), and diagnostic centers (xx%). Mergers and acquisitions (M&A) activity has been moderate, with deal values in recent years averaging approximately xx Million USD annually. Notable transactions include smaller acquisitions focused on enhancing technological capabilities or expanding regional reach.
- Market Concentration: Moderately concentrated, with key players holding significant shares.
- Innovation Catalysts: Digital mammography, tomosynthesis, AI diagnostics.
- Regulatory Landscape: TGA oversight influences market access and adoption.
- Substitute Products: Ultrasound, MRI; niche competition to mammography.
- End-User Profile: Hospitals, specialty clinics, and diagnostic centers.
- M&A Activity: Moderate, with xx Million USD average annual deal values (2019-2024).

Australia Mammography Market Industry Evolution
The Australian mammography market has experienced steady growth over the past few years, driven by increasing breast cancer incidence rates, rising awareness of early detection, and government initiatives promoting preventive healthcare. The market’s compound annual growth rate (CAGR) from 2019 to 2024 was estimated at xx%, with projections indicating a CAGR of xx% during the forecast period (2025-2033). This growth is significantly influenced by the adoption of advanced technologies like digital mammography and tomosynthesis, which offer improved image quality and diagnostic accuracy. The increasing adoption of AI-powered diagnostic tools is also contributing to market expansion. Furthermore, a shift in consumer demand toward minimally invasive procedures and faster diagnostic outcomes is shaping the industry. Government funding for cancer screening programs, along with increasing healthcare expenditure, further supports market growth. The transition from analog to digital systems is nearing completion, signifying the market’s progressive nature.
Leading Regions, Countries, or Segments in Australia Mammography Market
The Australian mammography market demonstrates strong performance across its key segments. The Digital Systems segment significantly dominates the Product Type category, holding approximately xx% of the market share in 2025 due to superior image quality and diagnostic capabilities compared to Analog Systems (xx%). Breast Tomosynthesis is experiencing rapid growth, with an estimated xx% market share in 2025 driven by its enhanced detection rates and reduced recall rates. Hospitals constitute the largest end-user segment, accounting for approximately xx% of the market share in 2025.
- Key Drivers for Digital Systems Dominance: Superior image quality, increased diagnostic accuracy, and technological advancements.
- Key Drivers for Breast Tomosynthesis Growth: Enhanced cancer detection rates, lower recall rates, and improved diagnostic confidence.
- Key Drivers for Hospital Segment Dominance: Higher patient volumes, dedicated radiology departments, and access to advanced technologies.
In-depth analysis: The dominance of digital systems reflects the widespread adoption of technologically advanced equipment providing improved image quality and diagnostic capabilities compared to analog systems. This reflects the increasing focus on providing high-quality diagnostic services which leads to superior patient outcomes. The rapid growth of breast tomosynthesis is due to its ability to significantly improve the detection of breast cancer at an earlier stage, leading to better patient outcomes and reduced costs associated with false-positive recalls. The dominance of the hospital segment stems from their infrastructure, expertise, and ability to handle higher patient volume, while also affording access to advanced diagnostic imaging technologies.
Australia Mammography Market Product Innovations
Recent innovations in the Australian mammography market focus on enhancing image quality, reducing radiation exposure, and improving diagnostic accuracy. Key advancements include AI-powered image analysis tools that aid radiologists in detecting subtle abnormalities and reducing false positives. The integration of 3D tomosynthesis has significantly improved lesion detection and characterization. These innovations aim to provide faster, more accurate diagnoses, improving patient outcomes and streamlining workflows for healthcare professionals. Unique selling propositions centre around improved diagnostic accuracy, reduced radiation doses, and streamlined workflows.
Propelling Factors for Australia Mammography Market Growth
Several factors are driving the growth of the Australian mammography market. Increased awareness of breast cancer and the importance of early detection fuels higher screening rates. Government initiatives promoting preventive healthcare and funding for cancer screening programs provide substantial support. Technological advancements, particularly in digital mammography and AI-powered diagnostics, are improving accuracy and efficiency. The aging population also contributes to higher demand for mammography services.
Obstacles in the Australia Mammography Market
Challenges faced by the Australian mammography market include the high cost of advanced equipment, which can limit accessibility in some regions. Supply chain disruptions, particularly exacerbated by global events, can impact equipment availability and increase costs. Competitive pressures from established players and new entrants require constant innovation and efficient service delivery. Regulatory hurdles, while intended to ensure quality, can also increase time and cost associated with product approvals.
Future Opportunities in Australia Mammography Market
Future opportunities lie in expanding access to advanced mammography technologies in underserved regions. The integration of AI and machine learning in image analysis offers significant potential for improving diagnostic accuracy and efficiency. Personalized medicine approaches and the development of new contrast agents could further enhance the effectiveness of mammography. Focus on remote patient monitoring and telemedicine will also unlock growth avenues.
Major Players in the Australia Mammography Market Ecosystem
- Siemens Healthineers (Siemens Healthineers)
- Hologic Inc (Hologic Inc)
- GE Healthcare (GE Healthcare)
- Koninklijke Philips NV (Koninklijke Philips NV)
- Sonologic
- Canon Medical Systems Corporation (Canon Medical Systems Corporation)
- Planmed Oy (Planmed Oy)
- Carestream Health Inc (Carestream Health Inc)
- Volpara Health Limited (Volpara Health Limited)
- Fujifilm Holdings Corporation (Fujifilm Holdings Corporation)
Key Developments in Australia Mammography Market Industry
- July 2021: BCAL Diagnostics listed on the Australian Securities Exchange, raising USD 10 Million. This signifies investor confidence in the Australian market and indicates growing opportunities in breast cancer diagnostics.
- June 2021: Keiron’s AI breast screening solution MIA received regulatory clearance. This development highlights the growing adoption of AI in enhancing diagnostic capabilities and improving efficiency in breast cancer screening.
Strategic Australia Mammography Market Forecast
The Australian mammography market is poised for continued growth, driven by technological advancements, increasing cancer awareness, and government support. The increasing adoption of AI-powered diagnostic tools and the expansion of breast tomosynthesis will contribute significantly to this growth. Further opportunities exist in enhancing access to advanced technologies in rural and remote areas. The market's future trajectory indicates significant potential for growth and innovation within the healthcare sector.
Australia Mammography Market Segmentation
-
1. Product Type
- 1.1. Digital Systems
- 1.2. Analog Systems
- 1.3. Breast Tomosynthesis
- 1.4. Other Product Types
-
2. End User
- 2.1. Hospitals
- 2.2. Specialty Clinics
- 2.3. Diagnostic Centers
Australia Mammography Market Segmentation By Geography
- 1. Australia

Australia Mammography Market REPORT HIGHLIGHTS
Aspects | Details |
---|---|
Study Period | 2019-2033 |
Base Year | 2024 |
Estimated Year | 2025 |
Forecast Period | 2025-2033 |
Historical Period | 2019-2024 |
Growth Rate | CAGR of 9.27% from 2019-2033 |
Segmentation |
|
Table of Contents
- 1. Introduction
- 1.1. Research Scope
- 1.2. Market Segmentation
- 1.3. Research Methodology
- 1.4. Definitions and Assumptions
- 2. Executive Summary
- 2.1. Introduction
- 3. Market Dynamics
- 3.1. Introduction
- 3.2. Market Drivers
- 3.2.1. Growing Burden of Breast Cancer; Technological Advancements in the Field of Breast Imaging
- 3.3. Market Restrains
- 3.3.1. Risk of Adverse Effects from Radiation Exposure
- 3.4. Market Trends
- 3.4.1. Diagnostic Centers are Expected to Witness Steady Growth Over the Forecast Period
- 4. Market Factor Analysis
- 4.1. Porters Five Forces
- 4.2. Supply/Value Chain
- 4.3. PESTEL analysis
- 4.4. Market Entropy
- 4.5. Patent/Trademark Analysis
- 5. Australia Mammography Market Analysis, Insights and Forecast, 2019-2031
- 5.1. Market Analysis, Insights and Forecast - by Product Type
- 5.1.1. Digital Systems
- 5.1.2. Analog Systems
- 5.1.3. Breast Tomosynthesis
- 5.1.4. Other Product Types
- 5.2. Market Analysis, Insights and Forecast - by End User
- 5.2.1. Hospitals
- 5.2.2. Specialty Clinics
- 5.2.3. Diagnostic Centers
- 5.3. Market Analysis, Insights and Forecast - by Region
- 5.3.1. Australia
- 5.1. Market Analysis, Insights and Forecast - by Product Type
- 6. Competitive Analysis
- 6.1. Market Share Analysis 2024
- 6.2. Company Profiles
- 6.2.1 Siemens Healthineers
- 6.2.1.1. Overview
- 6.2.1.2. Products
- 6.2.1.3. SWOT Analysis
- 6.2.1.4. Recent Developments
- 6.2.1.5. Financials (Based on Availability)
- 6.2.2 Hologic Inc
- 6.2.2.1. Overview
- 6.2.2.2. Products
- 6.2.2.3. SWOT Analysis
- 6.2.2.4. Recent Developments
- 6.2.2.5. Financials (Based on Availability)
- 6.2.3 GE Healthcare
- 6.2.3.1. Overview
- 6.2.3.2. Products
- 6.2.3.3. SWOT Analysis
- 6.2.3.4. Recent Developments
- 6.2.3.5. Financials (Based on Availability)
- 6.2.4 Koninklijke Philips NV
- 6.2.4.1. Overview
- 6.2.4.2. Products
- 6.2.4.3. SWOT Analysis
- 6.2.4.4. Recent Developments
- 6.2.4.5. Financials (Based on Availability)
- 6.2.5 Sonologic
- 6.2.5.1. Overview
- 6.2.5.2. Products
- 6.2.5.3. SWOT Analysis
- 6.2.5.4. Recent Developments
- 6.2.5.5. Financials (Based on Availability)
- 6.2.6 Canon Medical Systems Corporation
- 6.2.6.1. Overview
- 6.2.6.2. Products
- 6.2.6.3. SWOT Analysis
- 6.2.6.4. Recent Developments
- 6.2.6.5. Financials (Based on Availability)
- 6.2.7 Planmed Oy
- 6.2.7.1. Overview
- 6.2.7.2. Products
- 6.2.7.3. SWOT Analysis
- 6.2.7.4. Recent Developments
- 6.2.7.5. Financials (Based on Availability)
- 6.2.8 Carestream Health Inc
- 6.2.8.1. Overview
- 6.2.8.2. Products
- 6.2.8.3. SWOT Analysis
- 6.2.8.4. Recent Developments
- 6.2.8.5. Financials (Based on Availability)
- 6.2.9 Volpara Health Limited
- 6.2.9.1. Overview
- 6.2.9.2. Products
- 6.2.9.3. SWOT Analysis
- 6.2.9.4. Recent Developments
- 6.2.9.5. Financials (Based on Availability)
- 6.2.10 Fujifilm Holdings Corporation
- 6.2.10.1. Overview
- 6.2.10.2. Products
- 6.2.10.3. SWOT Analysis
- 6.2.10.4. Recent Developments
- 6.2.10.5. Financials (Based on Availability)
- 6.2.1 Siemens Healthineers
List of Figures
- Figure 1: Australia Mammography Market Revenue Breakdown (Million, %) by Product 2024 & 2032
- Figure 2: Australia Mammography Market Share (%) by Company 2024
List of Tables
- Table 1: Australia Mammography Market Revenue Million Forecast, by Region 2019 & 2032
- Table 2: Australia Mammography Market Revenue Million Forecast, by Product Type 2019 & 2032
- Table 3: Australia Mammography Market Revenue Million Forecast, by End User 2019 & 2032
- Table 4: Australia Mammography Market Revenue Million Forecast, by Region 2019 & 2032
- Table 5: Australia Mammography Market Revenue Million Forecast, by Country 2019 & 2032
- Table 6: Australia Mammography Market Revenue Million Forecast, by Product Type 2019 & 2032
- Table 7: Australia Mammography Market Revenue Million Forecast, by End User 2019 & 2032
- Table 8: Australia Mammography Market Revenue Million Forecast, by Country 2019 & 2032
Frequently Asked Questions
1. What is the projected Compound Annual Growth Rate (CAGR) of the Australia Mammography Market?
The projected CAGR is approximately 9.27%.
2. Which companies are prominent players in the Australia Mammography Market?
Key companies in the market include Siemens Healthineers, Hologic Inc, GE Healthcare, Koninklijke Philips NV, Sonologic, Canon Medical Systems Corporation, Planmed Oy, Carestream Health Inc, Volpara Health Limited, Fujifilm Holdings Corporation.
3. What are the main segments of the Australia Mammography Market?
The market segments include Product Type, End User.
4. Can you provide details about the market size?
The market size is estimated to be USD 69.28 Million as of 2022.
5. What are some drivers contributing to market growth?
Growing Burden of Breast Cancer; Technological Advancements in the Field of Breast Imaging.
6. What are the notable trends driving market growth?
Diagnostic Centers are Expected to Witness Steady Growth Over the Forecast Period.
7. Are there any restraints impacting market growth?
Risk of Adverse Effects from Radiation Exposure.
8. Can you provide examples of recent developments in the market?
In July 2021, breast cancer screening and diagnostic company BCAL diagnostics were listed on the Australian securities exchange following an initial public offering that raised USD 10 million from investors.
9. What pricing options are available for accessing the report?
Pricing options include single-user, multi-user, and enterprise licenses priced at USD 3800, USD 4500, and USD 5800 respectively.
10. Is the market size provided in terms of value or volume?
The market size is provided in terms of value, measured in Million.
11. Are there any specific market keywords associated with the report?
Yes, the market keyword associated with the report is "Australia Mammography Market," which aids in identifying and referencing the specific market segment covered.
12. How do I determine which pricing option suits my needs best?
The pricing options vary based on user requirements and access needs. Individual users may opt for single-user licenses, while businesses requiring broader access may choose multi-user or enterprise licenses for cost-effective access to the report.
13. Are there any additional resources or data provided in the Australia Mammography Market report?
While the report offers comprehensive insights, it's advisable to review the specific contents or supplementary materials provided to ascertain if additional resources or data are available.
14. How can I stay updated on further developments or reports in the Australia Mammography Market?
To stay informed about further developments, trends, and reports in the Australia Mammography Market, consider subscribing to industry newsletters, following relevant companies and organizations, or regularly checking reputable industry news sources and publications.
Methodology
Step 1 - Identification of Relevant Samples Size from Population Database



Step 2 - Approaches for Defining Global Market Size (Value, Volume* & Price*)

Note*: In applicable scenarios
Step 3 - Data Sources
Primary Research
- Web Analytics
- Survey Reports
- Research Institute
- Latest Research Reports
- Opinion Leaders
Secondary Research
- Annual Reports
- White Paper
- Latest Press Release
- Industry Association
- Paid Database
- Investor Presentations

Step 4 - Data Triangulation
Involves using different sources of information in order to increase the validity of a study
These sources are likely to be stakeholders in a program - participants, other researchers, program staff, other community members, and so on.
Then we put all data in single framework & apply various statistical tools to find out the dynamic on the market.
During the analysis stage, feedback from the stakeholder groups would be compared to determine areas of agreement as well as areas of divergence